Patient-Related Factors Associated with Adherence to Recommendations Made by a Fracture Liaison Service: A Mixed-Method Prospective Study

Int J Environ Res Public Health. 2018 May 9;15(5):944. doi: 10.3390/ijerph15050944.

Abstract

A Fracture Liaison Service (FLS) has been calculated to be a cost-effective model of care for patients with fragility fracture (FF). Cost-effectiveness can be achieved when adherence to bone health recommendations from FLS staff is high. This prospective study combined participants’ telephone longitudinal survey data (intervention group, n = 354) and interviews with 16 individuals from FLS in three health regions of the province of Quebec (Canada). Participants were recruited between January 2013 and April 2015. Regression models were fit to examine the relationship between participant-related factors and adherence at 12 months to osteoporosis medication, vitamin D supplementation, and participation in physical activity. Participants acknowledging FF as a consequence of osteoporosis were more likely to adhere to medication (odds ratio (OR) 2.5; p = 0.001) and vitamin D supplementation (OR 2.3; p = 0.01). Paradoxically, the same participants were less prone to engage in physical activity (OR 0.5, p = 0.01). Qualitative interviews suggested that feedback from FLS coordinators helped participants understand the underlying cause of their FF. This study highlighted the key roles of FLS staff in helping patients to recognize FF as a sign of underlying bone disease and encouraging adherence to care recommendations.

Keywords: Fracture Liaison Service; adherence; fragility fracture; health behaviors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cost-Benefit Analysis
  • Exercise
  • Female
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis* / complications
  • Osteoporosis* / economics
  • Osteoporosis* / therapy
  • Osteoporotic Fractures / prevention & control*
  • Patient Care Team
  • Patient Compliance
  • Prospective Studies
  • Quebec
  • Secondary Prevention / methods
  • Vitamin D / therapeutic use

Substances

  • Vitamin D

Grants and funding